supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTmouse nuclear extract; soleus muscle myoblast cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; histiocytic lymphoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; colorectal adenocarcinoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; neuroepithelioma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; Burkitt's lymphoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; prostate adenocarcinoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; acute lymphoblastic leukemia cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; chronic myelogenous leukemia cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; mammary adenocarcinoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; neuroblastoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; acute promyelocytic leukemia cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; leukemic lymphoblast cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; B cell lymphoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTrat nuclear extract; Raf-1 transformed fibroblast cells induced with phorbolsuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTrat nuclear extract; Raf-1 transformed fibroblast cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTrat nuclear extract; K-Ras transformed kidney cells induced with phorbolsuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTrat nuclear extract; K-Ras transformed kidney cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTmouse nuclear extract; myeloma cells induced with phorbolsuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTmouse nuclear extract; myeloma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTTmouse nuclear extract; normal embryo fibroblast cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; amelanotic melanoma cells induced with phorbolsuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; amelanotic melanoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; breast adenocarcinoma cells induced with phorbolsuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; breast adenocarcinoma cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; acute T cell leukemia cells induced with phorbolsuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; acute T cell leukemia cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; chronic myelogenous leukemia cells induced with phorbolsuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

supplied in four vials, each containing 250 µg nuclear extract in 50 µl bufferprovided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTThuman nuclear extract; chronic myelogenous leukemia cellssuitable for use in Gel Shift and Western Blotting assaysExtracts should be stored at -70°C and repeated freezing and thawing should be avoided.prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475